EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES
Clinical trials for EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES trials appear
Sign up with your email to follow new studies for EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare cancers: expanded access to DFMO drug
Disease control AVAILABLEThis study offers expanded access to the drug DFMO for children and young adults (ages 0-30) with rare relapsed tumors like neuroblastoma or medulloblastoma that have certain genetic markers. The goal is to provide treatment when no other options are available, aiming to control …
Matched conditions: EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES
Sponsor: Giselle Sholler • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New hope for toddlers with rare brain cancers: targeted chemo combo under study
Disease control Recruiting nowThis early-phase study tests whether adding a chemotherapy drug (topotecan) given into the spinal fluid, followed by maintenance chemo, is safe and feasible for children under 6 with high-risk embryonal brain tumors. The goal is to improve cancer control after standard high-dose …
Matched conditions: EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated May 18, 2026 12:03 UTC